Skip to content

Experimental study on the health benefits of intake okara powder.

Experimental study on the health benefits of intake okara powder. - Experimental study on the health benefits of intake okara powder.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046288
Enrollment
30
Registered
2021-12-06
Start date
2021-12-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Intake 15g or more of okara powder for four weeks.

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Adults who are 30 years old or more and under 70 years old 3.Persons whose stool frequency is 3-4 times per week

Exclusion criteria

Exclusion criteria: 1.Persons who have chronic illness, receiving medication, have a serious disease history 2.Persons who are allergic to the test food 3.Persons who usually take a large amount of test food 4.Persons who usually take medicine, specified health food, healthy food and supplements that may have microenvironment 5.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 6.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding 7.Persons who have been judged ineligible by the study supervising physician or principal investigator

Design outcomes

Primary

MeasureTime frame
Urinary indoxyl sulfate at the beginning or after the intake for four weeks.

Secondary

MeasureTime frame
Questionnaire(about defecation, sleep and skin), urinary urea nitrogen and salivary IgA at the beginning or after the intake for four weeks.

Countries

Japan

Contacts

Public ContactMari Shimura

Healthcare Systems Co., Ltd. Research and Development Department

shimura.mari@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026